High-Durability Nitinol for Medical Devices: A 100 Million-Cycle Bending Fatigue Characterization Study

ORIGINAL RESEARCH ARTICLE High-Durability Nitinol for Medical Devices: A One Hundred Million-Cycle Bending Fatigue Characterization Study

Abstract This study investigates the bending fatigue performance of Vacuum Arc Remelted/Electron Beam Refined Nitinol for cardiovascular applications. Diamond-shaped fatigue specimens were manufactured from ultra-clean Nitinol tubing with inclusion sizes below ten micrometers and tested under physiologically relevant conditions to one hundred million cycles. Testing included multiple combinations of mean strains (zero to seven percent) and strain amplitudes (zero point seven five to two point five zero percent) to simulate in vivo conditions for cardiovascular devices. Results demonstrate that Nitinol exhibits as high as two hundred seventy-five percent improvement in one hundred eight-cycle Fatigue Strain Limit compared to conventional Nitinol at mean strains between three and five percent. The Fatigue Strain Limit behavior shows three distinct strain regimes: increasing Fatigue Strain Limit with mean strains from zero to three percent, plateau between three and five percent, and decreasing Fatigue Strain Limit beyond five percent. Analysis confirms the critical impact of limiting inclusion size below the theoretical critical small crack length of ten micrometers, where fatigue performance becomes dictated by cyclic stress/strain rather than flaw size. Advanced (S)TEM imaging of the fatigue specimens provides evidence that advanced thermomechanical processing leads to stable microstructures to enhance fatigue response up to ten degree fatigue cycles.

Introduction

Nitinol, a nearly equiatomic nickel-titanium alloy, is a prominent material in biomedical engineering due to its exceptional shape memory properties, superelasticity, and biocompatibility. The material's capacity for recoverable strain accommodation up to eight percent through temperature- and stress-induced martensitic transformations has enabled significant advances in minimally invasive medical procedures. Within the last decade, significant technological advancements in the melting, processing, manufacturing, and modeling of Nitinol have allowed it to emerge as a material of choice for critical and challenging applications such as Class Three life-supporting and life-sustaining medical devices.

The durability requirements for Nitinol cardiovascular devices, including heart valve frames, are governed by stringent international standards, as well as guidance from regulatory bodies, including the International Organization for Standardization, the United States Food and Drug Administration, and various American Society for Testing and Materials specifications. Recent regulatory developments emphasized comprehensive fatigue analysis protocols that encompass anatomical boundary conditions, stress/strain analysis, material fatigue strength assessment, component fatigue demonstration, and safety factor calculations. In regulating prosthetic heart valves, the United States Food and Drug Administration challenges device manufacturers to identify the proper boundary conditions for in vitro testing, and with the performance of new materials such as Nitinol in the dynamic environment of heart valve implantation sites. The regulatory framework for cardiovascular devices necessitates fatigue resistance verification for extended service lives: four hundred million cycles (ten years) per International Organization for Standardization and six hundred million cycles (fifteen years) per United States Food and Drug Administration guidelines.

Recent fatigue studies expanded investigation parameters to include multiple mean strains and strain amplitudes, that use coupons extracted from the device or surrogate specimens, including, but not limited to, diamond-, Z-, or C-shaped manufactured from tubing, wire or sheet with pre-strain conditions that mimic cardiovascular implant applications. These investigations identified several strategies to enhance in vivo fatigue resistance, namely:

one. Optimization of pre-strain (crimp strain) parameters two. Control of mean strain (oversizing) conditions three. Stress-strain (energy) consideration four. Optimization of material, including thermomechanical processing (e.g., reduction of grain size) and micropurity (reduction of inclusion size)